HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xinping Liu Selected Research

Discoidin Domain Receptor 2

12/2014Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia.
3/2014A host deficiency of discoidin domain receptor 2 (DDR2) inhibits both tumour angiogenesis and metastasis.
3/2013Increased expression of discoidin domain receptor 2 (DDR2): a novel independent prognostic marker of worse outcome in breast cancer patients.
10/2009Discoidin domain receptor 2 is associated with the increased expression of matrix metalloproteinase-13 in synovial fibroblasts of rheumatoid arthritis.
9/2007Fusion expression of DDR2 extracellular domain in insect cells and its purification and function characterization.
10/2006Expression of discoidin domain receptor 2 (DDR2) extracellular domain in pichia pastoris and functional analysis in synovial fibroblasts and NIT3T3 cells.
11/2002Functional analysis of discoidin domain receptor 2 in synovial fibroblasts in rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xinping Liu Research Topics

Disease

18Neoplasms (Cancer)
01/2021 - 10/2006
9Neoplasm Metastasis (Metastasis)
01/2021 - 10/2006
6Breast Neoplasms (Breast Cancer)
09/2020 - 12/2006
5Rheumatoid Arthritis
10/2009 - 10/2002
4Glioma (Gliomas)
08/2014 - 09/2003
3Hypoxia (Hypoxemia)
12/2019 - 01/2008
2Mitochondrial Diseases (Mitochondrial Disease)
01/2021 - 07/2012
2Carcinogenesis
01/2021 - 09/2015
2Alzheimer Disease (Alzheimer's Disease)
09/2019 - 01/2019
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2019 - 01/2016
2Infarction (Infarctions)
01/2019 - 01/2016
2Inflammation (Inflammations)
10/2016 - 10/2002
2Stomach Neoplasms (Stomach Cancer)
04/2013 - 09/2008
2Glioblastoma (Glioblastoma Multiforme)
11/2009 - 09/2003
2Leukemia
05/2005 - 01/2004
1Insulin Resistance
01/2021
1Weight Gain
01/2021
1Triple Negative Breast Neoplasms
01/2021
1Hypersensitivity (Allergy)
01/2021
1Reperfusion Injury
01/2019
1Hepatocellular Carcinoma (Hepatoma)
01/2019
1Ventricular Remodeling
01/2019
1Heart Failure
01/2018
1Necrosis
01/2018
1Ischemia
01/2016
1Colorectal Neoplasms (Colorectal Cancer)
09/2015
1Lymphatic Metastasis
12/2014
1Hyperthermia
04/2013
1Disease Progression
07/2012
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2011
1Cryptorchidism (Undescended Testes)
04/2010
1Adenoma (Adenomas)
10/2008
1Thyroid Neoplasms (Thyroid Cancer)
10/2008
1Carcinoma (Carcinomatosis)
10/2008
1Adenocarcinoma
09/2008

Drug/Important Bio-Agent (IBA)

7Discoidin Domain Receptor 2IBA
12/2014 - 11/2002
7Proteins (Proteins, Gene)FDA Link
08/2014 - 10/2006
7Messenger RNA (mRNA)IBA
08/2014 - 06/2007
6CollagenIBA
12/2014 - 10/2002
3LigandsIBA
01/2021 - 10/2006
3Phospholipases (Phospholipase)IBA
01/2021 - 01/2016
3AntigensIBA
09/2020 - 05/2005
3Neoplasm Antigens (Tumor Antigens)IBA
03/2008 - 01/2004
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2007 - 11/2002
3Complementary DNA (cDNA)IBA
05/2005 - 09/2003
2Biological ProductsIBA
01/2021 - 11/2009
2Mitochondrial Permeability Transition PoreIBA
01/2021 - 01/2018
2CalciumIBA
01/2021 - 01/2016
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2021 - 01/2018
2Oxygen (Dioxygen)IBA
11/2020 - 12/2019
2AcidsIBA
11/2020 - 01/2018
2Carcinoembryonic AntigenIBA
09/2020 - 05/2019
2Amyloid (Amyloid Fibrils)IBA
09/2019 - 01/2019
2Histones (Histone)IBA
02/2012 - 01/2008
2Small Interfering RNA (siRNA)IBA
02/2012 - 11/2009
2Protein Sorting Signals (Signal Peptide)IBA
09/2007 - 10/2006
1Liposomes (Liposome)IBA
01/2021
112-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA
01/2021
1Polysaccharides (Glycans)IBA
01/2021
1Adenosine Diphosphate (ADP)IBA
01/2021
1Protein CoronaIBA
01/2021
1Peroxidase (Myeloperoxidase)IBA
11/2020
1Glucose OxidaseIBA
11/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2020
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
09/2020
1Glutathione (Reduced Glutathione)IBA
12/2019
1IonsIBA
12/2019
1Free RadicalsIBA
12/2019
1MetalsIBA
12/2019
1Biomarkers (Surrogate Marker)IBA
05/2019
1CarbohydratesIBA
05/2019
1GemcitabineFDA Link
01/2019
1Hydroxyeicosatetraenoic Acids (HETE)IBA
01/2018
1EicosanoidsIBA
10/2016
1LipidsIBA
10/2016
1Fatty Acids (Saturated Fatty Acids)IBA
01/2016
1EnzymesIBA
09/2015
1Lactic Acid (Lactate)FDA LinkGeneric
09/2015
1Glutamic Acid (Glutamate)FDA Link
09/2015
1Glucose (Dextrose)FDA LinkGeneric
09/2015
1Glutamine (L-Glutamine)FDA Link
09/2015
1Biocompatible Materials (Biomaterials)IBA
09/2015
1Cadherins (E-Cadherin)IBA
12/2014
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2014
11,3- dihydro- 1- (1- ((4- (6- phenyl- 1H- imidazo(4,5- g)quinoxalin- 7- yl)phenyl)methyl)- 4- piperidinyl)- 2H- benzimidazol- 2- oneIBA
04/2013
1Discoidin Domain ReceptorsIBA
03/2013
1cardiolipin synthetaseIBA
07/2012
1Cardiolipins (Cardiolipin)IBA
07/2012
1Histone Deacetylases (Histone Deacetylase)IBA
02/2012
1trichostatin A (A 300)IBA
02/2012
1AgarIBA
11/2009
1Matrix Metalloproteinase 13IBA
10/2009
1Vincristine (Oncovin)FDA LinkGeneric
09/2008
1Pharmaceutical PreparationsIBA
09/2008
1calebin-AIBA
09/2008

Therapy/Procedure

3Therapeutics
11/2020 - 09/2007
1Ligation
01/2019
1Induced Hyperthermia (Thermotherapy)
04/2013
1Aftercare (After-Treatment)
04/2013
1Operative Surgical Procedures
04/2010